Human kinase and polynucleotides encoding the same

Details Human kinase and polynucleotides encoding the same Human kinase and polynucleotides encoding the same

2002-03-20

2004-07-06

Monshipouri, Maryam (Department: 1652)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S194000, C435S320100, C435S006120, C435S252300, C536S023100

Reexamination Certificate

active

06759527

ABSTRACT:

INTRODUCTION
The present invention relates to the discovery, identification, and characterization of novel human polynucleotides encoding a kinase which share sequence similarity with animal kinases. The invention encompasses the described polynucleotides, host cell expression systems, the encoded proteins, fusion proteins, polypeptides and peptides, antibodies to the encoded proteins and peptides, and genetically engineered animals that either lack or overexpress the disclosed genes, antagonists and agonists of the proteins, and other compounds that modulate the expression or activity of the proteins encoded by the disclosed genes, which can be used for diagnosis, drug screening, clinical trial monitoring, the treatment of diseases and disorders, and cosmetic or nutriceutical applications.
BACKGROUND OF THE INVENTION
Kinases mediate the phosphorylation of a wide variety of proteins and compounds in the cell. In conjunction with phosphatases, kinases are involved in a range of regulatory pathways. Given the physiological importance of kinases, they have been subject to intense scrutiny and are proven drug targets.
SUMMARY OF THE INVENTION
The present invention relates to the discovery, identification, and characterization of nucleotides that encode novel a human kinase and the corresponding amino acid sequence of this protein. The novel human kinases (NHK) described for the first time herein shares structural similarity with animal kinases, including, but not limited to, receptor tyrosine kinases and especially kinases of the membrane-associated guanylate kinase (MAGUK) family. The described NHK encoding sequences define a novel kinase having homologues and orthologs across a range of phyla and species.
The novel human polynucleotide described herein, encode an open reading frame (ORF) of 455 amino acids in length (see SEQ ID NO: 2).
The invention also encompasses agonists and antagonists of the described NHK, including small molecules, large molecules, mutant NHKs, or portions thereof, that compete with native NHK, peptides, and antibodies, as well as nucleotide sequences that can be used to inhibit the expression of the described NHK (e.g., antisense and ribozyme molecules, and open reading frame or regulatory sequence replacement constructs) or to enhance the expression of the described NHK (e.g., expression constructs that place the described polynucleotide under the control of a strong promoter system), and transgenic animals that express a NHK sequence, or “knock-outs” (which can be conditional) that do not express a functional NHK. Such knock-out mice can be produced in several ways, one of which involves the use of mouse embryonic stem cell (“ES cells”) lines that contain gene trap mutations in a murine homolog the described NHK. When the unique NHK sequences described in SEQ ID NOS:1-2 are “knocked-out” they provide a method of identifying phenotypic expression of the particular gene as well as a method of assigning function to previously unknown genes. In addition, animals in which the unique NHK sequences described in SEQ ID NOS:1-2 are “knocked-out” provide a unique source in which to elicit antibodies to homologous and orthologous proteins which would have been previously viewed by the immune system as “self” and therefore would have failed to elicit significant antibody responses.
Additionally, the unique NHK sequences described in SEQ ID NOS:1-2 are useful for the identification of protein coding sequence and mapping a unique gene to a particular chromosome. These sequences identify actual, biologically verified, and therefore relevant, exon splice junctions as opposed to those that may have been bioinformatically predicted from genomic sequence alone. The sequences of the present invention are also useful as additional DNA markers for restriction fragment length polymorphism (RFLP) analysis, and in forensic biology.
Further, the present invention also relates to processes for identifying compounds that modulate, i.e., act as agonists or antagonists, of NHK expression and/or NHK activity that utilize purified preparations of the described NHK and/or NHK products, or cells expressing the same. Such compounds can be used as therapeutic agents for the treatment of any of a wide variety of symptoms associated with biological disorders or imbalances.


REFERENCES:
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4594595 (1986-06-01), Struckman
patent: 4631211 (1986-12-01), Houghten
patent: 4689405 (1987-08-01), Frank et al.
patent: 4713326 (1987-12-01), Dattagupta et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5252743 (1993-10-01), Barrett et al.
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5556752 (1996-09-01), Lockhart et al.
patent: 5700637 (1997-12-01), Southern
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5817479 (1998-10-01), Au-Young et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5869336 (1999-02-01), Meyer et al.
patent: 5877397 (1999-03-01), Lonberg et al.
patent: 5948767 (1999-09-01), Scheule et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6110490 (2000-08-01), Thierry
patent: 6117679 (2000-09-01), Stemmer
patent: 6150584 (2000-11-01), Kucherlapati et al.
Inagaki et al., BBRC, 265, 462-468, 1999.*
Bird et al, 1988, “Single-Chain Antigen-Binding Proteins”, Science 242:423-426.
Bitter et al, 1987, “Expression and Secretion Vectors for Yeast”, Methods in Enzymology 153:516-544.
Colbere-Garapin et al, 1961, “A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells”, J. Mol. Biol, 150:1-14.
Gautier et al, 1987, “&agr;-DNA IV:&agr;-anomeric and &bgr;-anomeric tetrathymidylates covalently inked to Intercalating oxazolopyridocarbazole. Synthesis, physiochemical properities and Poly (rA) binding”, Nucleic Acids Research 15(16):6625-6641.
Gordon, 1989, “Transgenic Animals”, International Review of Cytology, 115:171-229.
Greenspan et al, 1993, “Idiotypes: Structure and immunogenicity”, FASEB Journal 7:437-444.
Gu et al, 1994, “Deletion of a DNA Polymerase &bgr; Gene Segment in T Cells Using Cell Type-Specific Gene Targeting”, Science 265:103-106.
Huse et al, 1989, “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”, Science 246:1275-1281.
Huston et al, 1988, “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain FV analogue produced In Escherichia ooll”, Proc. Natl. Acad. Sci. USA 85:5879-5883.
Inoue et al, 1987, “Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and R Nase H”, FEBS Letters 215(2):327-330.
Inoue et al, 1987, “Synthesis and hybridization studies on two com{overscore (p)}lementary nona(2'-O-methyl)ribonucleotides”, Nucleic Acids Research 15(15):6131-6149.
Inouye & Inouye, 1985,“Up-promoter mutations in the Ipp gene of Escherichia coli”, Nucleic Acids Research 13(9):3101-3110.
Janknecht et al,1991, “Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinla virus”, PNAS 88:8972-8976.
Kohlar & Milstein,1975, “Continuous cultures of fused cells secreting antibody at predefined specificity”, Nature 256:495-497.
Lakso et al, 1992, “Targeted oncogene activation by site-specific recombination in transgenic mice”, Proc. Natl. Acad. Sci. USA 89:6232-6236.
Lavitrano et al, 1989, “Sperm Cells as Vectors for Introducing Foreign DNA into Eggs: Genetic Transformation of Mice”, Cells 57:717-723.
Lo, 1983, “Transformation by Iontophoretic Microinjection of DNA: Multiple Integrations without Tandem Insertions”, Mol. & Cell. Biology 3(10) :1803-1814.
Logan et al, 1964, “Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection”, Proc. Natl. Acad. Sci. USA 81:3655-3659.
Lowy et al, 1980, “Isolatio

Affiliated with

Also associated with

Rating

Human kinase and polynucleotides encoding the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human kinase and polynucleotides encoding the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human kinase and polynucleotides encoding the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3258601